Allergens from plant-based food allergen sources and their clinical and diagnostic relevance [0.03%]
植物基食物过敏原来源及其临床和诊断意义的过敏原
Eva-Maria Rick,Melanie Plum,Marua Abu Risha et al.
Eva-Maria Rick et al.
Lately, a rise of plant-related food allergies could be observed following the increase of plant-based food consumption. This narrative review provides an overview of important plant allergens from the most common allergen sources including...
Choosing and switching biologics for patients with severe asthma: Real-world data from the German Asthma Net (GAN) [0.03%]
德国哮喘网络（GAN）重度哮喘患者生物制剂的选择和转换：真实世界数据
Alexandra Lenoir,Roland Buhl,Carlo Muemmler et al.
Alexandra Lenoir et al.
With six biologics available to treat severe asthma in 2025, choosing the optimal initial therapy and deciding to which other biologic to switch in case of insufficient benefit is challenging. To better understand patients' characteristics ...
Contact allergy to a titanium port catheter: Diagnostic challenges and clinical resolution [0.03%]
钛端口输液港的接触过敏：诊断挑战及临床对策
Silas Fugger,Alexander Kauffmann,Heinrich Dickel
Silas Fugger
Background: Titanium and its alloys are widely used in modern medical devices because of their favorable biocompatibility and mechanical properties. Allergic reactions to titanium-based implants are considered rare, and t...
Case Reports
Allergologie select. 2026 Jul 1:10:145-150. DOI:10.5414/ALX02637E 2026
In vitro IgE diagnostics in inhalant allergy: Plant and mold allergens [0.03%]
吸入性过敏原体外IgE诊断中的植物和霉菌过敏原
Regina Treudler
Regina Treudler
Respiratory allergies represent one of the most prevalent immune-mediated disorders worldwide, such as allergic rhinitis and asthma. The advent of in vitro diagnostic methods, particularly those based on molecular allergology, has revolutio...
Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation [0.03%]
特应性皮炎证据及共识的S3指南更新：生物制剂或JAK抑制剂系统治疗以及系统治疗在妊娠和哺乳期的特殊问题
Thomas Werfel,Annice Heratizadeh,Matthias Augustin et al.
Thomas Werfel et al.
This guideline is a partial update of the S3 guideline on atopic dermatitis (AWMF register no. 013-027) published in 2023. The chapters on systemic therapy with biologics and Janus kinase inhibitors as well as the chapter on pregnancy, brea...
Resolution of childhood wheat allergy through evolution into WALDA? A case report [0.03%]
儿童小麦过敏经WALDA演变而消失的病例报告
Charlotte J Kiani,Valentina Faihs,Claudia Kugler et al.
Charlotte J Kiani et al.
Background: Wheat allergy may present with different phenotypes. Childhood-onset wheat allergy is characterized by immediate-type IgE-mediated reactions to wheat ingestion alone. It typically affects atopic individuals an...
Case Reports
Allergologie select. 2026 Jun 16:10:114-119. DOI:10.5414/ALX02631E 2026
Phila Cara Baumann,Lennart Matthias Roesner
Phila Cara Baumann
This review provides an overview of recent advances in understanding T-cell inflammation in atopic dermatitis (AD), a common chronic inflammatory skin disease. After recognizing their cognate antigen in the acute phase of the disease, the h...
Cefazolin as an alternative in patients with a history of penicillin or β-lactam antibiotic allergy: A case overview [0.03%]
青霉素或β-内酰胺类抗生素过敏患者的替代药物：头孢唑林——个例综述
Burkhard Kreft,Johannes Wohlrab,Cord Sunderkötter
Burkhard Kreft
Many patients with suspected or confirmed allergy to penicillin or β-lactam antibiotics are unnecessarily denied all β-lactam antibiotics (BLA) and instead given a less effective antibiotic with more side effects. However, cefazolin, a fi...
Case Reports
Allergologie select. 2026 May 29:10:101-106. DOI:10.5414/ALX02634E 2026
Does the teicoplanin skin test predict IgE-mediated hypersensitivity? [0.03%]
teicoplanin皮试能预测IgE介导的过敏反应吗？
Nur Betül Baştuğ İnan,Özge Göktürk,Yavuz Karahan et al.
Nur Betül Baştuğ İnan et al.
Various delayed-type hypersensitivity reactions have been reported following teicoplanin administration, including drug rash with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP). Un...
Case Reports
Allergologie select. 2026 May 21:10:98-100. DOI:10.5414/ALX02632E 2026
Expert consensus on the long-term use of lanadelumab in hereditary angioedema: Toward harmonized care [0.03%]
长效C5补体抑制剂拉那利尤单抗治疗遗传性血管性水肿的长期应用专家共识：迈向规范化治疗
Emel Aygören-Pürsün,Jens Greve,Inmaculada Martinez-Saguer et al.
Emel Aygören-Pürsün et al.
Background: Hereditary angioedema (HAE) is a rare, potentially life-threatening disease caused in most cases by C1 inhibitor deficiency. Lanadelumab, a monoclonal antibody targeting plasma kallikrein, is an effective long...